Spain, El Palmar 
Dr. Antonio Lázaro Sánchez is a Medical Oncologist and Doctor of Health Sciences with a professional profile focused on clinical excellence, healthcare management, translational research, cancer immunology, biomarkers, and artificial intelligence applied to oncology. He currently serves as Assistant Specialist Physician in Medical Oncology at Virgen de la Arrixaca University Hospital and is President of the Foundation for Cancer Research in the Region of Murcia.
Current Position
- Assistant Specialist Physician, Medical Oncology, Virgen de la Arrixaca University Hospital, Murcia Health Service
- President, Foundation for Cancer Research in the Region of Murcia (FICAM)
- Member of the Executive Committee of the +MIR Section, Spanish Society of Medical Oncology (SEOM)
Education
- Doctorate in Public Health, Medical and Surgical Sciences, Miguel Hernández University of Elche, awarded Sobresaliente cum laude
- Specialized healthcare training in Medical Oncology, San Juan University Hospital, Alicante
- Master’s Degree in Healthcare Management, Miguel Hernández University of Elche
- Master’s Degree in Medical Oncology, Universitat de Girona
- Master’s Degree in Clinical Medicine Research, Miguel Hernández University of Elche
- Graduate in Medicine, University of Murcia
- Expert in the evaluation of medicines and health technologies in the Spanish National Health System, Universidad Nacional de Educación a Distancia
- Colorectal Cancer Training Course, Francisco de Vitoria University
- Expert in immunology and immunotherapy in cancer, Francisco de Vitoria University
Professional Experience
- Research Coordinator for Health Area II, Cartagena University Hospital Complex
- Associate Specialist in Medical Oncology, Santa Lucía University General Hospital
- Medical Director Oncology, QUIBIM S.L.
- Investigator, Translational Oncology Division, Fundación Jiménez Díaz
- Investigator, Early Phase Clinical Trials Unit, Fundación Jiménez Díaz
- Medical Oncology Resident, Hospital Universitari Sant Joan d’Alacant
Research / Publications / Academic Activity
- Principal investigator of the project “Role of fascina inhibitors in reversing oxaliplatin chemoresistance and response to immunotherapy in colon cancer”
- Participated in research projects and clinical studies including the CÁRPATOS Study, CIRCOLA Project, ATractiB Clinical Trial, and Gepardouze Clinical Trial
- Research activity focuses on cancer immunology, therapeutic innovation, biomarkers, HLA-G/HLA-E, colorectal cancer, docetaxel resistance, cytokine release syndrome, and artificial intelligence applied to oncology
- Author and co-author of scientific publications in journals including International Journal of Environmental Research and Public Health, Clinical and Translational Oncology, Frontiers in Oncology, European Radiology, International Journal of Molecular Sciences, Scientific Reports, Journal of Clinical Medicine, Cancers, Cancer Control, and Respirology Case Reports
- Presented scientific work at the 9th IMIB Conference, SEOM Congress 2024, and Miguel Hernández University of Elche
- External internship supervisor in Medicine at Santa Lucía University General Hospital, San Juan University Hospital, Alicante, and Morales Meseguer University General Hospital
- Supervising an ongoing doctoral thesis on the histological, molecular, and immunological characterization of non-clear cell renal carcinomas
Additional Information
- Member of the Digestive Tumors Treatment Group, European Association for Cancer Research, Spanish Association for Cancer Research, and Spanish Society of Medical Oncology
- Peer reviewer for Scientific Reports
- Editorial board member for Journal of Clinical Oncology and Cancer Therapy
- Completed additional training in oncogenomics, cancer immunotherapy research study design, leadership, project management, liquid biopsy, clinical research, clinical trials, and Good Clinical Practice